Noxopharm and UNSW Pancreatic Cancer Research Accepted at Leading US Conference • Noxopharm and University of New South Wales to present pancreatic cancer research • ChromaTM drug candidates tested with pioneering patient explant model using tissue taken from pancreatic cancer patients during surgery • Low survival rates mean urgent need for better treatments in pancreatic cancer
The AACR’s Special Conference on Pancreatic Cancer is a leading cancer forum that attracts approximately 500 global leaders in pancreatic cancer research and treatment, and covers the latest cutting-edge advances in the field. It will take place from 13-16 September 2022 in Boston, Massachusetts.
Maybe this will help?
NOX Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
